| Previous Close | 162.78 |
| Open | 163.20 |
| Bid | 162.53 x 800 |
| Ask | 162.56 x 800 |
| Day's Range | 161.81 - 164.14 |
| 52 Week Range | 109.16 - 164.14 |
| Volume | 5,187,090 |
| Avg. Volume | 7,423,637 |
| Market Cap | 427.445B |
| Beta (5Y Monthly) | 0.70 |
| PE Ratio (TTM) | 25.53 |
| EPS (TTM) | 6.36 |
| Earnings Date | Jan. 26, 2021 |
| Forward Dividend & Yield | 4.04 (2.48%) |
| Ex-Dividend Date | Feb. 22, 2021 |
| 1y Target Est | 167.59 |
- Yahoo Finance UK
The OUTstanding Top 100 LGBT+ Future Leaders 2020
All of the future leaders in this list — who, once they identify as LGBT+, can be in any position in a company, can be any nationality, and based in any country — were nominated by peers and colleagues, or put themselves forward.
- Zacks
J&J's (JNJ) Darzalex Faspro Gets FDA Nod for Amyloidosis
J&J (JNJ) gets accelerated approval for a new indication of Darzalex Faspro in combination with bortezomib, cyclophosphamide and dexamethasone for treating amyloidosis patients.
- Reuters
South Africa is promised 9 million J&J vaccine shots - Business Day
South Africa, which has yet to receive its first coronavirus vaccine, has been promised 9 million doses by Johnson & Johnson, the Business Day newspaper reported on Monday, citing a health ministry spokeswoman. The government of Africa's most advanced economy is scrambling to secure enough COVID-19 vaccines, after health workers and scientists publicly criticised it for not moving fast enough to inoculate its people. The country has recorded more than 1.3 million infections and more than 37,000 deaths related to the virus, the most in Africa.
